The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Buhl, Peter
    Director born in April 1955
    Individual (4 offsprings)
    Officer
    2020-04-15 ~ now
    OF - Director → CIF 0
    Mr Peter Buhl
    Born in April 1955
    Individual (4 offsprings)
    Person with significant control
    2020-04-15 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Gardiner, Andrew David
    Company Director born in June 1963
    Individual (7 offsprings)
    Officer
    2021-03-03 ~ now
    OF - Director → CIF 0
  • 3
    Goldsmith, Neil
    Director born in April 1963
    Individual (7 offsprings)
    Officer
    2020-04-15 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

AIDA ONCOLOGY LIMITED

Previous name
CHOSA ONCOLOGY LTD - 2022-12-06
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02023-05-01 ~ 2024-04-30
02022-05-01 ~ 2023-04-30
Debtors
5,683 GBP2024-04-30
5,511 GBP2023-04-30
Cash at bank and in hand
17,656 GBP2024-04-30
21,536 GBP2023-04-30
Current Assets
23,339 GBP2024-04-30
27,047 GBP2023-04-30
Creditors
Current
32,611 GBP2024-04-30
35,018 GBP2023-04-30
Net Current Assets/Liabilities
-9,272 GBP2024-04-30
-7,971 GBP2023-04-30
Total Assets Less Current Liabilities
-9,272 GBP2024-04-30
-7,971 GBP2023-04-30
Equity
Called up share capital
1,000 GBP2024-04-30
1,000 GBP2023-04-30
Retained earnings (accumulated losses)
-10,272 GBP2024-04-30
-8,971 GBP2023-04-30
Equity
-9,272 GBP2024-04-30
-7,971 GBP2023-04-30
Other Debtors
Amounts falling due within one year, Current
5,683 GBP2024-04-30
5,511 GBP2023-04-30
Trade Creditors/Trade Payables
Current
-1 GBP2024-04-30
216 GBP2023-04-30
Other Taxation & Social Security Payable
Current
255 GBP2023-04-30
Other Creditors
Current
32,612 GBP2024-04-30
34,547 GBP2023-04-30

  • AIDA ONCOLOGY LIMITED
    Info
    CHOSA ONCOLOGY LTD - 2022-12-06
    Registered number 12557227
    London Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH
    Private Limited Company incorporated on 2020-04-15 (5 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-14
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.